Patent applications published 13 April 2011
Selected patent applications from the weekly European Patents Bulletin
- Formulations of 5-fluorocysteine and uses thereof
Tocagen 2306823*
- Iontophoretic delivery of curcumin and curcumin analogues for the treatment of Alzheimer’s disease
Codman and Surtleff 2306824*
- Inhibitors of AKT activity
GlaxoSmithKline 2306825*
- Salts of methyl 2-((R))-(3-chloro-phenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate
Vitae Pharmaceuticals 2306826*
- Prolyl hydroxylase inhibitors
GlaxoSmithKline 2306828*
- Particles containing an opioid receptor antagonist and methods of use
University of Chicago 2306829*
- Use of mifepristone for the treatment of amyotrophic lateral sclerosis
Corcept Therapeutics 2306830*
- BMI-1 protein expression modulators
PTC Therapeutics 2306836*
- Compsn for external skin application containing pine knot extract and method for preparation of the same
Amorepacific 2306969*
- Unit dosage of apadenoson
University of Virginia Patent Foundation 2306971*
- Acetic acid and a buffer
Danmarks Tekniske Universiteit 2306972*
- Vaginal suppository comprising lactic acid
Rolf Kullgren 2306973*
- A topical compsn comprising the isolated non-polar lipid fraction of lanolin4
Universiteit Leiden; Universiteit Utrecht Holding; Stichting Voor de Technische Wetenschappen 2306974*
- Controlled release otic structure modulating and innate immune system modulating compsns and methods for the treatment of otic disorders
Otonomy; The Regents of the University of California 2306975*
- Injectable taxane pharmaceutical compsn
GP Pharm 2306976*
- Method and compsn for treating ocular hypertension and glaucoma
Santen Pharmaceutical; Asahi Glass 2306977*
- Compsns for the in vivo delivery of RNAI agents
Mirna Therapeutics 2306978*
- Liposomes capable of effectively binding the beta amyloid peptide
Università Degli Studi di Milano - Bicocca 2306979*
- Powders for reconstitution
Tibotec Pharmaceuticals 2306980*
- A transmucosal delivery system
University of the Witwatersrand 2306981*
- Pharmaceutical compsns of rosuvastatin calcium
Abdi Ibrahim Ilas Sanayi Ve Ticaret Anonim Sirketi 2306982*
- A gastroretentive pharmaceutical dosage form
University of the Witwatersrand 2306983*
- Pharmaceutical dosage form for the site-specific delivery of more than one active pharmaceutical ingredient
University of the Witwatersrand 2306984*
- Controlled release compsns of agents that reduce circulating levels of platelets and methods therefor
Biovascular 2306985*
- Prodrugs and drug-macromolecule conju-gates having controlled drug release rates
Prolynx 2306986*
- Method for coating tablets
BASF 2306987*
- Pharmaceutical formulation for treating the upper digestive tract
Dr Falk Pharma 2306988*
- Fenofibrate formulation with enhanced oral bioavailability
Panacea Biotec 2306989*
- Pharmaceutical compsn comprising N-[2-(diethylamino_ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
Ratiopharm 2306990*
- Injectable delivery of microparticles and compsns therefore
Tepha; Surmodics Pharmaceuticals 2306991*
- Delivery particle
Appleton Papers 2306992*
- Protamine/RNA nanoparticles for immunostimulation
Universität Zurich 2306993*
- S1P1 receptor agonists and use thereof
Amgen 2306994*
- Antitumour properties of NO modified protease inhibitors
Ganial Immunotherapeutics 2306995*
- Use of HDAC inhibitors for the treatment of Hodgkin’s disease
Novartis 2306996*
- Treatment of ringworm
Vernolix 2306997*
- Pharmaceutical formulation
Alphapharm 2306998*
- Compsns for treating rosacea
Polichem 2306999*
- Combination of pilocarpin and methimazol for treating charcot-marie-tooth disease and related disorders
Pharnext 2307000*
- Control of blood vessel physiology to treat skin disorders
BioChemics 2307001*
- Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine
Cyclacel 2307002*
- Combination therapy with PM00104 and another antitumour agent
Pharma Mar 2307003*